Polyactives: controlled and sustained bioactive release via hydrolytic degradation

Biomaterials Science

Volumn 3, Issue 8, 2015, Pages 1171-1187

  Stebbins, N D ^a   Faig, J J ^a   Yu, W ^b   Guliyev, R ^a   Uhrich, K E ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION;

BIOCOMPATIBLE POLYMER; CONTROLLED RELEASE; HYDROLYTIC DEGRADATION; POLYMER DESIGNS; POLYMER FIELDS; POLYMER RESIDUE; PROCESSABILITY; SMALL MOLECULES;

BIODEGRADABLE POLYMERS;

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; COPOLYMER; NONSTEROID ANTIINFLAMMATORY AGENT; POLYMER; PROPIONIC ACID; BIOMATERIAL; HYDROGEN PEROXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADATION; BIOLOGICAL ACTIVITY; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; HYDROLYSIS; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SYNTHESIS; CHEMISTRY; POLYMERIZATION;

BIOCOMPATIBLE MATERIALS; HYDROGEN PEROXIDE; HYDROLYSIS; NITRIC OXIDE SYNTHASE; POLYMERIZATION;

EID: 84937250079     PISSN: 20474830     EISSN: 20474849     Source Type: Journal    
DOI: 10.1039/c5bm00051c     Document Type: Article

References (114)

1. N. Rapoport Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery Prog. Polym. Sci. 2007 32 8-9 962 990
2. M.-H. Li P. Keller Stimuli-responsive polymer vesicles Soft Matter 2009 5 5 927 937
3. M. C. Branco J. P. Schneider Self-assembling materials for therapeutic delivery Acta Biomater. 2009 5 3 817 831
4. A. Kumari S. K. Yadav S. C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf., B 2010 75 1 1 18
5. S. Fredenberg M. Wahlgren M. Reslow A. Axelsson The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems-a review Int. J. Pharm. 2011 415 1-2 34 52
6. P. Tanner P. Baumann R. Enea O. Onaca C. Palivan W. Meier Polymeric vesicles: From drug carriers to nanoreactors and artificial organelles Acc. Chem. Res. 2011 44 10 1039 1049
7. H. K. Makadia S. J. Siegel Poly lactic-co-glycolic acid (plga) as biodegradable controlled drug delivery carrier Polymers 2011 3 3 1377 1397
8. R. T. Chacko J. Ventura J. Zhuang S. Thayumanavan Polymer nanogels: A versatile nanoscopic drug delivery platform Adv. Drug Delivery Rev. 2012 64 9 836 851
9. T. K. Dash V. B. Konkimalla Poly-∈-caprolactone based formulations for drug delivery and tissue engineering: A review J. Controlled Release 2012 158 1 15 33
10. F. Danhier E. Ansorena J. M. Silva R. Coco A. Le Breton V. Preat Plga-based nanoparticles: An overview of biomedical applications J. Controlled Release 2012 161 2 505 522
11. Q. Zhang N. R. Ko J. K. Oh Recent advances in stimuli-responsive degradable block copolymer micelles: Synthesis and controlled drug delivery applications Chem. Commun. 2012 48 61 7542 7552
12. S. Krishnamurthy R. Vaiyapuri L. Zhang J. M. Chan Lipid-coated polymeric nanoparticles for cancer drug delivery Biomater. Sci. 2015 10.1039/C4BM00427B
13. X. S. Wu Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part iii. Drug delivery application Artif. Cells, Blood Substitutes, Biotechnol. 2004 32 4 575 591
14. S.-W. Kim Y.-Z. Shi J.-Y. Kim K.-N. Park J.-X. Cheng Overcoming the barriers in micellar drug delivery: Loading efficiency, in vivo stability, and micelle-cell interaction Expert Opin. Drug Delivery 2010 7 1 49 62
15. S. Liu R. Maheshwari K. L. Kiick Polymer-based therapeutics Macromolecules 2009 42 1 3 13
16. K. Ulbrich V. Subr Structural and chemical aspects of hpma copolymers as drug carriers Adv. Drug Delivery Rev. 2010 62 2 150 166
17. N. Larson H. Ghandehari Polymeric conjugates for drug delivery Chem. Mater. 2012 24 5 840 853
18. A. J. M. D'Souza E. M. Topp Release from polymeric prodrugs: Linkages and their degradation J. Pharm. Sci. 2004 93 8 1962 1979
19. K. Hoste K. De Winne E. Schacht Polymeric prodrugs Int. J. Pharm. 2004 277 1-2 119 131
20. J. Khandare T. Minko Polymer-drug conjugates: Progress in polymeric prodrugs Prog. Polym. Sci. 2006 31 4 359 397
21. R. Haag F. Kratz Polymer therapeutics: Concepts and applications Angew. Chem., Int. Ed. 2006 45 8 1198 1215
22. G. Pasut F. M. Veronese Peg conjugates in clinical development or use as anticancer agents: An overview Adv. Drug Delivery Rev. 2009 61 13 1177 1188
23. J. Kopecek P. Kopeckova Hpma copolymers: Origins, early developments, present, and future Adv. Drug Delivery Rev. 2010 62 2 122 149
24. R. Mahato W. Tai K. Cheng Prodrugs for improving tumor targetability and efficiency Adv. Drug Delivery Rev. 2011 63 8 659 670
25. B. Obermeier F. Wurm C. Mangold H. Frey Multifunctional poly(ethylene glycol)s Angew. Chem., Int. Ed. 2011 50 35 7988 7997
26. A. Gopferich J. Tessmar Polyanhydride degradation and erosion Adv. Drug Delivery Rev. 2002 54 7 911 931
27. A. Goepferich Mechanisms of polymer degradation and erosion Biomaterials 1996 17 2 103 114
28. K. Whitaker-Brothers K. Uhrich Investigation into the erosion mechanism of salicylate-based poly(anhydride-esters) J. Biomed. Mater. Res., Part A 2006 76A 3 470 479
29. R. C. Schmeltzer M. Johnson J. Griffin K. Uhrich Comparison of salicylate-based poly(anhydride-esters) formed via melt-condensation versus solution polymerization J. Biomater. Sci., Polym. Ed. 2008 19 10 1295 1306
30. R. C. S. Schmeltzer K. E. Uhrich Synthesis and cytotoxicity of salicylate-based poly(anhydride esters) Biomacromolecules 2005 6 1 359 367
31. T. J. U. Anastasiou K. E. Uhrich Aminosalicylate-based biodegradable polymers- syntheses and in vitro characterization of poly(anhydride-ester)s and poly(anhydride-amide)s J. Polym. Sci., Part A: Polym. Chem. 2003 413667 413679
32. R. Rosario-Melendez W. Yu K. E. Uhrich Biodegradable polyesters containing ibuprofen and naproxen as pendant groups Biomacromolecules 2013 14 10 3542 3548
33. N. D. Stebbins W. Yu K. E. Uhrich Enzymatic polymerization of an ibuprofen-containing monomer and subsequent drug release Macromol. Biosci. 2015 10.1002/mabi.201500030
34. T. Finkel N. J. Holbrook Oxidants, oxidative stress and the biology of ageing Nature 2000 408 6809 239 247
35. B. K. Tiwari V. P. Valdramidis C. P. O'Donnell K. Muthukumarappan P. Bourke P. J. Cullen Application of natural antimicrobials for food preservation J. Agric. Food Chem. 2009 57 14 5987 6000
36. D. L. Simmons R. M. Botting T. Hla Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition Pharmacol. Rev. 2004 56 3 387 437
37. G. McDonnell A. D. Russell Antiseptics and disinfectants: Activity, action, and resistance Clin. Microbiol. Rev. 1999 12 1 147 179
38. M. A. Kohanski D. J. Dwyer J. J. Collins How antibiotics kill bacteria: From targets to networks Nat. Rev. Microbiol. 2010 8 6 423 435
39. R. Przewlocki B. Przewlocka Opioids in chronic pain Eur. J. Pharmacol. 2001 429 1-3 79 91
40. P. M. Brooks R. O. Day Nonsteroidal antiinflammatory drugs-differences and similarities N. Engl. J. Med. 1991 324 24 1716 1725
41. P. Anastas N. Eghbali Green chemistry: Principles and practice Chem. Soc. Rev. 2010 39 1 301 312
42. A. Mahapatro A. Kumar B. Kalra R. A. Gross Solvent-free adipic acid/1,8-octanediol condensation polymerizations catalyzed by candida antartica lipase b Macromolecules 2003 37 1 35 40
43. A. Sakakura K. Kawajiri T. Ohkubo Y. Kosugi K. Ishihara Widely useful dmap-catalyzed esterification under auxiliary base-free and solvent-free conditions J. Am. Chem. Soc. 2007 129 47 14775 14779
44. K. Watanabe N. Yamagiwa Y. Torisawa Cyclopentyl methyl ether as a new and alternative process solvent Org. Process Res. Dev. 2007 11 2 251 258
45. C. J. Thompson D. Hansford D. L. Munday S. Higgins C. Rostron G. A. Hutcheon Synthesis and evaluation of novel polyester-ibuprofen conjugates for modified drug release Drug Dev. Ind. Pharm. 2008 34 8 877 884
46. H.-Y. Wang W.-W. Zhang N. Wang C. Li K. Li X.-Q. Yu Biocatalytic synthesis and in vitro release of biodegradable linear polyesters with pendant ketoprofen Biomacromolecules 2010 11 12 3290 3293
47. M. Valko D. Leibfritz J. Moncol M. T. D. Cronin M. Mazur J. Telser Free radicals and antioxidants in normal physiological functions and human disease Int. J. Biochem. Cell Biol. 2006 39 1 44 84
48. C.-W. Lin C.-W. Yu S.-C. Wu K.-H. Yih Dpph free-radical scavenging activity, total phenolic contents and chemical composition analysis of forty-two kinds of essential oils Yaowu Shipin Fenxi 2009 17 5 386 395
49. S. Burt Essential oils: Their antibacterial properties and potential applications in foods-a review Int. J. Food Microbiol. 2004 94 3 223 253
50. S.-J. Lee K. Umano T. Shibamoto K.-G. Lee Identification of volatile components in basil (ocimum basilicum l.) and thyme leaves (thymus vulgaris l.) and their antioxidant properties Food Chem. 2004 91 1 131 137
51. K. Chaieb H. Hajlaoui T. Zmantar K.-N. A. Ben M. Rouabhia K. Mahdouani A. Bakhrouf The chemical composition and biological activity of clove essential oil, eugenia caryophyllata (syzigium aromaticum l. Myrtaceae): A short review Phytother. Res. 2007 21 6 501 506
52. N. Kumar R. S. Langer A. J. Domb Polyanhydrides: An overview Adv. Drug Delivery Rev. 2002 54 7 889 910
53. A. Prudencio A. L. Carbone J. Griffin K. E. Uhrich A novel approach for incorporation of mono-functional bioactive phenols into polyanhydrides Macromol. Rapid Commun. 2009 30 13 1101 1108
54. A. L. Carbone-Howell N. D. Stebbins K. E. Uhrich Poly(anhydride-esters) comprised exclusively of naturally occurring antimicrobials and EDTA: Antioxidant and antibacterial activities Biomacromolecules 2014 15 5 1889 1895
55. J. H. Jorgensen, J. D. Turnidge and J. A. Washington, Manual of clinical microbiology, ASM Press, Washington DC, 7th edn, 1999, pp. 1526-1543
56. J. G. Mahdi A. J. Mahdi I. D. Bowen The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential Cell Proliferation 2006 39 2 147 155
57. R. K. Madan J. Levitt A review of toxicity from topical salicylic acid preparations J. Am. Acad. Dermatol. 2014 70 4 788 792
58. P. Mao Z. Liu M. Xie R. Jiang W. Liu X. Wang S. Meng G. She Naturally occurring methyl salicylate glycosides Mini-Rev. Med. Chem. 2014 1456 1463
59. M. Rowland S. Riegelman Pharmacokinetics of acetylsalicylic acid after intravenous administration in man J. Pharm. Sci. 1968 57 8 1313 1319
60. R. C. Schmeltzer T. J. Anastasiou K. E. Uhrich Optimized synthesis of salicylate-based poly(anhydride-esters) Polym. Bull. (Berlin, Ger.) 2003 49 6 441 448
61. Y. Kim K. E. Uhrich Synthesis and characterization of 5-aminosalicylic acid based poly(anhydride-esters) by solution polymerization J. Polym. Sci., Part A: Polym. Chem. 2010 48 24 6003 6008
62. A. L. Carbone M. Song K. E. Uhrich Iodinated salicylate-based poly(anhydride-esters) as radiopaque biomaterials Biomacromolecules 2008 9 6 1604 1612
63. A. Prudencio R. C. Schmeltzer K. E. Uhrich Effect of linker structure on salicylic acid-derived poly(anhydride-esters) Macromolecules 2005 38 16 6895 6901
64. J. J. Faig, K. Smith and K. E. Uhrich, Exploring green methods through a one-pot salicylic acid-based poly(anhydride-ester) synthesis, 248th ACS Meeting&Exposition, (San Francisco, CA), 2014, pp. POLY-489
65. M. A. Rogers Y. F. Yan K. Ben-Elazar Y. Lan J. Faig K. Smith K. E. Uhrich Salicylic acid (sa) bioaccessibility from sa-based poly(anhydride-ester) Biomacromolecules 2014 15 9 3406 3411
66. J. D. Bryers R. A. Jarvis J. Lebo A. Prudencio T. R. Kyriakides K. Uhrich Biodegradation of poly(anhydride-esters) into non-steroidal anti-inflammatory drugs and their effect on pseudomonas aeruginosa biofilms in vitro and on the foreign-body response in vivo Biomaterials 2006 27 29 5039 5048
67. L. E. Rosenberg A. L. Carbone U. Romling K. E. Uhrich M. L. Chikindas Salicylic acid-based poly(anhydride esters) for control of biofilm formation in salmonella enterica serovar typhimurium Lett. Appl. Microbiol. 2008 46 5 593 599
68. K. Wada W. Yu M. Elazizi S. Barakat M. A. Ouimet R. Rosario-Melendez J. P. Fiorellini D. T. Graves K. E. Uhrich Locally delivered salicylic acid from a poly(anhydride-ester): Impact on diabetic bone regeneration J. Controlled Release 2013 171 1 33 37
69. Y. Chandorkar R. K. Bhagat G. Madras B. Basu Cross-linked, biodegradable, cytocompatible salicylic acid based polyesters for localized, sustained delivery of salicylic acid: An in vitro study Biomacromolecules 2014 15 3 863 875
70. Y. Chandorkar N. Bhaskar G. Madras B. Basu Long-term sustained release of salicylic acid from cross-linked biodegradable polyester induces a reduced foreign body response in mice Biomacromolecules 2015 16 2 636 649
71. A. Prudencio, J. Faig, M. Sung and K. Uhrich, Phenolic acid-based poly(anhydride-esters) as antioxidant biomaterials, 2015, in preparation
72. M. A. Ouimet J. Griffin A. L. Carbone-Howell W. H. Wu N. D. Stebbins R. Di K. E. Uhrich Biodegradable ferulic acid-containing poly(anhydride-ester): Degradation products with controlled release and sustained antioxidant activity Biomacromolecules 2013 14 3 854 861
73. M. A. Ouimet N. D. Stebbins K. E. Uhrich Biodegradable coumaric acid-based poly(anhydride-ester) synthesis and subsequent controlled release Macromol. Rapid Commun. 2013 34 15 1231 1236
74. Q. Wang X. Gao H. Gong X. Lin D. Saint-Leger J. Senee Chemical stability and degradation mechanisms of ferulic acid (f.A) within various cosmetic formulations J. Cosmet. Sci. 2011 62483 62503
75. P. P. Wattamwar Y. Mo R. Wan R. Palli Q. Zhang T. D. Dziubla Antioxidant activity of degradable polymer poly(trolox ester) to suppress oxidative stress injury in the cells Adv. Funct. Mater. 2010 20 1 147 154
76. P. P. Wattamwar S. S. Hardas D. A. Butterfield K. W. Anderson T. D. Dziubla Tuning of the pro-oxidant and antioxidant activity of trolox through the controlled release from biodegradable poly(trolox ester) polymers J. Biomed. Mater. Res., Part A 2011 99 2 184 191
77. S. Kim H. Park Y. Song D. Hong O. Kim E. Jo G. Khang D. Lee Reduction of oxidative stress by p-hydroxybenzyl alcohol-containing biodegradable polyoxalate nanoparticulate antioxidant Biomaterials 2011 32 11 3021 3029
78. H. Park S. Kim S. Kim Y. Song K. Seung D. Hong G. Khang D. Lee Antioxidant and anti-inflammatory activities of hydroxybenzyl alcohol releasing biodegradable polyoxalate nanoparticles Biomacromolecules 2010 112103 112108
79. J. Kwon J. Kim S. Park G. Khang P. M. Kang D. Lee Inflammation-responsive antioxidant nanoparticles based on a polymeric prodrug of vanillin Biomacromolecules 2013 14 5 1618 1626
80. R. C. Schmeltzer K. E. Uhrich Synthesis and characterization of antiseptic-based poly(anhydride-esters) Polym. Bull. 2006 57 3 281 291
81. D. Livermore Can better prescribing turn the tide of resistance? Nat. Rev. Microbiol. 2004 2 1 73 78
82. G. D. Wright Bacterial resistance to antibiotics: Enzymatic degradation and modification Adv. Drug Delivery Rev. 2005 57 10 1451 1470
83. P. Wu D. W. Grainger Drug/device combinations for local drug therapies and infection prophylaxis Biomaterials 2006 27 11 2450 2467
84. J. Kost and R. Langer, Responsive polymeric delivery systems, Adv. Drug Delivery Rev., 2001, 46 1-3, 125 148
85. A. Prudencio N. D. Stebbins M. Johnson M. Song B. A. Langowski K. E. Uhrich Polymeric prodrugs of ampicillin as antibacterial coatings J. Bioact. Compat. Polym. 2014 29 3 208 220
86. G. W. Hanks F. de Conno N. Cherny M. Hanna E. Kalso H. J. McQuay S. Mercadante J. Meynadier P. Poulain C. Ripamonti L. Radbruch J. R. i. Casas J. Sawe R. G. Twycross V. Ventafridda F. De Conno A. Caraceni N. Chemy J. F. Goncalves C. J. Furst G. W. Hanks S. Kaasa S. Mercadante J. M. N. Olarte P. Poulain L. Radbruch C. Ripamonti F. Stiefel Morphine and alternative opioids in cancer pain: The EAPC recommendations Br. J. Cancer 2001 84 5 587 593
87. R. N. Upton T. J. Semple P. E. Macintyre Pharmacokinetic optimization of opioid treatment in acute pain therapy Clin. Pharmacokinet. 1997 33 3 225 244
88. J. Mao D. D. Price D. J. Mayer Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions Pain 1995 62 3 259 274
89. D. E. Joranson K. M. Ryan A. M. Gilson J. L. Dahl Trends in medical use and abuse of opioid analgesics JAMA 2000 283 13 1710 1714
90. C. P. Bailey M. Connor Opioids: Cellular mechanisms of tolerance and physical dependence Curr. Opin. Pharmacol. 2005 5 1 60 68
91. R. Rosario-Melendez C. L. Harris R. Delgado-Rivera L. Yu K. E. Uhrich Polymorphine: An innovative biodegradable polymer drug for extended pain relief J. Controlled Release 2012 162 3 538 544
92. K. Whitaker-Brothers K. Uhrich Poly(anhydride-ester) fibers: Role of copolymer composition on hydrolytic degradation and mechanical properties J. Biomed. Mater. Res., Part 2004 70 2 309 318
93. J. Griffin R. Delgado-Rivera S. Meiners K. E. Uhrich Salicylic acid-derived poly(anhydride-ester) electrospun fibers designed for regenerating the peripheral nervous system J. Biomed. Mater. Res., Part A 2011 97 3 230 242
94. M. A. Ouimet R. Fogaca S. S. Snyder S. Sathaye L. H. Catalani D. J. Pochan K. E. Uhrich Poly(anhydride-ester) and poly(n-vinyl-2-pyrrolidone) blends: Salicylic acid-releasing blends with hydrogel-like properties that reduce inflammation Macromol. Biosci. 2015 15 3 342 350
95. M. L. Johnson K. E. Uhrich Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters) J. Biomed. Mater. Res., Part A 2009 91 3 671 678
96. R. L. Delgado-Rivera R. Rosario-Melendez K. E. Uhrich Salicylate-based poly (anhydrideesters): A dual system delivery of fibroblast growth factor-2 and the suppression of inflammation Polym. Prepr. 2010 51598 51599
97. M. A. Ouimet S. S. Snyder K. E. Uhrich Tunable drug release profiles from salicylate-based poly (anhydride-ester) matrices using small molecule admixtures J. Bioact. Compat. Polym. 2012 27 6 540 549
98. R. Delgado-Rivera R. Rosario-Melendez W. Yu K. E. Uhrich Biodegradable salicylate-based poly(anhydride-ester) microspheres for controlled insulin delivery J. Biomed. Mater. Res., Part A 2014 102 8 2736 2742
99. W. Ebstein, Zur therapie des diabetes mellitus, insbesondere über die anwendung des salicylsauren natron bei demselben, E. W., Berliner Klinische Wochenschrift, 1876, vol. 13, pp. 337-340
100. D. Zegers de Beyl R. Naeije A. de Troyer Demeclocycline treatment of water retention in congestive heart failure Br Med J 1978 1 6115 760
101. F. Yan D. B. Polk Aminosalicylic acid inhibits ikappab kinase alpha phosphorylation of ikappabalpha in mouse intestinal epithelial cells J. Biol. Chem. 1999 274 51 36631 36636
102. R. S. Hundal K. F. Petersen A. B. Mayerson P. S. Randhawa S. Inzucchi S. E. Shoelson G. I. Shulman Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes J. Clin. Invest. 2002 109 10 1321 1326
103. W. Ebstein Invited comment on w. Ebstein: On the therapy of diabetes mellitus, in particular on the application of sodium salicylate J. Mol. Med. 2002 80 10 618
104. S. E. Shoelson J. Lee M. Yuan Inflammation and the ikk beta/i kappa b/nf-kappa b axis in obesity- and diet-induced insulin resistance Int. J. Obes. Relat. Metab. Disord. 2003 27 Suppl 3 S49 S52
105. G. Jiang Q. Dallas-Yang F. Liu D. E. Moller B. B. Zhang Salicylic acid reverses phorbol 12-myristate-13-acetate (pma)- and tumor necrosis factor alpha (tnfalpha)-induced insulin receptor substrate 1 (irs1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (hek293) cells J. Biol. Chem. 2003 278 1 180 186
106. M. C. Arkan A. L. Hevener F. R. Greten S. Maeda Z. W. Li J. M. Long A. Wynshaw-Boris G. Poli J. Olefsky M. Karin Ikk-beta links inflammation to obesity-induced insulin resistance Nat. Med. 2005 11 2 191 198
107. Y. S. Lee, In vivo evaluation of nerve guidance conduits comprised of a salicylic acid-based poly(anhydride-ester) blend, 2012, Retrieved from / 10.7282/T3ZP44WH, p
108. C. T. Keith A. A. Borisy B. R. Stockwell Multicomponent therapeutics for networked systems Nat. Rev. Drug Discovery 2005 4 1 71-U10
109. M. Harries P. Ellis P. Harper Nanoparticle albumin-bound paclitaxel for metastatic breast cancer J. Clin. Oncol. 2005 23 31 7768 7771
110. M. H. Smith L. A. Lyon Multifunctional nanogels for sirna delivery Acc. Chem. Res. 2012 45 7 985 993
111. G. Shim S. E. Han Y. H. Yu S. Lee H. Y. Lee K. Kim I. C. Kwon T. G. Park Y. B. Kim Y. S. Choi C. W. Kim Y. K. Oh Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of sirna and an anticancer drug J. Controlled Release 2011 155 1 60 66
112. D. Sutton N. Nasongkla E. Blanco J. M. Gao Functionalized micellar systems for cancer targeted drug delivery Pharm. Res. 2007 24 6 1029 1046
113. F. Greco M. J. Vicent Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines Adv. Drug Delivery Rev. 2009 61 13 1203 1213
114. C.-M. J. Hu S. Aryal L. Zhang Nanoparticle-assisted combination therapies for effective cancer treatment Ther. Delivery 2010 1 2 323 334